A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
Welén et al., European Urology, doi:10.1016/j.eururo.2021.12.013
https://c19early.org/welen2.html